drugset / Trial / NCT00752635
Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to evaluate the effectiveness and safety of norgestimate-ethinyl estradiol as comparted with cyproterone acetate-ethinyl estradiol among female patients with moderate acne vulgaris.
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyproterone acetate-ethinyl estradiol | Unknown | — | — |
| Subject | Ortho Tri-Cyclen LO | Unknown | 0.18 mg | Oral |
| Subject | Ortho Tri-Cyclen LO | Unknown | 0.215 mg | Oral |
| Subject | Ortho Tri-Cyclen LO | Unknown | 0.25 mg | Oral |